Systemic hypertension in postmenopausal women: A clinical approach

Current Hypertension Reports

Volumn 4, Issue 6, 2002, Pages 464-470

  Fisman, Enrique Z ^a   Tenenbaum, Alexander ^b   Pines, Amos ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; REVIEW; RISK FACTOR; WOMEN'S HEALTH;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPERTENSION; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; WOMEN'S HEALTH;

EID: 0036886503     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0027-0     Document Type: Article

References (53)

1. Glendy RE, Levine SA, White PD: Coronary disease in youth: comparison of 100 patients under 40 with 300 persons past 80. JAMA 1937, 109: 1775-1781.
2. Witteman JC, Grobbee DE, Kok FJ, et al.: Increased risk of atherosclerosis in women after the menopause. BMJ 1989, 298: 642-644.
3. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow up of the Framingham population. Am Heart J 1986, 111: 383-390.
4. Sigurdsson JA: High blood pressure in women: a cross-sectional and a longitudinal follow-up study. Acta Med Scand 1983, 669(Suppl): 1-39.
5. Miall WE, Lovell HG: Relation between change of blood pressure and age. BMJ 1977, 2: 660-664.
6. Landahl S, Bengtsson C, Sigurdsson JA, et al.: Age-related changes in blood pressure. Hypertension 1986, 8: 1044-1049.
7. Wilson PWF, Garrison RJ, Castelli WP: Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: The Framingham Study. N Engl J Med 1985, 313: 1038-1043.
8. Staessen J, Bulpitt CJ, Fagard R, et al.: The influence of menopause on blood pressure. J Hum Hypertens 1989, 3: 427-433.
9. Wassertheil-Smoller S, Anderson G, Psaty BM, et al.: Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000, 36: 780-789.
10. Pines A, Fisman EZ, Levo Y, et al.: Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1993, 72: 240-241.
11. Hinderliter AL, Sherwood A, Blumenthal JA, et al.: Changes in hemodynamics and left ventricular structure after menopause. Am J Cardiol 2002, 89: 830-833.
12. Tenenbaum A, Fisman EZ, Pines A, et al.: Gender paradox in cardiac calcium deposits in middle-aged and elderly patients: mitral annular and coronary calcifications interrelationship. Maturitas 2000, 36: 35-42.
13. Pines A, Fisman EZ, Shemesh J, et al.: Menopause-related changes in left ventricular function in healthy women. Cardiology 1992, 80: 413-416.
14. Pines A, Fisman EZ, Levo Y, et al.: The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 1991, 164: 806-812.
15. Mercuro G, Zoncu S, Cherchi A, et al.: Can menopause be considered an independent risk factor for cardiovascular disease? Ital Heart J 2001, 2: 719-727.
16. Chowienczyk PJ, Watts GF, Cockroft JR, et al.: Sex differences in endothelial function in normal and hypercholesterolemic subjects. Lancet 1994, 334: 305-306.
17. Wolinsky H: Response of the rat aortic media to hypertension. Morphological and clinical studies. Circ Res 1970, 26: 507-512.
18. Staessen JA, van der Heijden-Spek JJ, Safar ME, et al.: Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001, 15: 511-518.
19. Reaven G: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37: 1595-1607.
20. Walton C, Godsland IF, Proudler A, et al.: The effects of the menopause on insulin sensitivity, secretion and elimination in nonobese, healthy women. Eur J Clin Invest 1993, 23: 466-473.
21. Aronson D, Rayfield EJ: How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002, 1: 1.
22. Spencer CP, Godsland IF, Stevenson JC: Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997, 11: 341-355.
23. Rosenthal T, Oparil S: Hypertension in women. J Hum Hypertens 2000, 14: 691-704.
24. Magness RR, Rosenfeld CR: Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. Am J Physiol 1989, 256:E536-E542.
25. Pines A, Fisman EZ, Ayalon D, et al.: Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women. Chest 1992, 102: 1494-1498.
26. Pines A, Fisman EZ, Shapira I, et al.: Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension. Am J Cardiol 1996, 78: 1385-1389.
27. Fisman EZ, Tenenbaum A, Shapira I, et al.: The acute effects of sublingual estradiol on left ventricular diastolic function in normotensive and hypertensive postmenopausal women. Maturitas 1999, 33: 145-152.
28. Fisman EZ, Tenenbaum A, Shapira I, et al.: Lack of effects of transdermal estradiol on diastolic function: a randomized placebo-controlled double-blind short-term trial. Climacteric 1999, 2: 174-180.
29. Lind T, Cameron EC, Hunter WM, et al.: A prospective controlled trial of six forms of hormone replacement therapy given to post-menopausal women. Br J Obstet Gynecol 1979, 86(Suppl 3): 1-9.
30. Barrett-Connor E, Brown WV, Turner J, et al.: Heart disease risk factors and hormone use in postmenopausal women. JAMA 1979, 241: 2167-2169.
31. Affinito P, Palomba F, Bonifacio M, et al.: Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas 2001, 40: 75-83.
32. Writing Group for the PEPI Trial: Effects of estrogen and estro-gen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995, 273: 199-208.
33. Hayward CS, Samaras K, Campbell L, et al.: Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens 2001, 14(7 Pt 1): 699-703.
34. Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension 2001, 37: 1199-1208.
35. Pines A, Fisman EZ, Drory Y, et al.: The effects of sublingual estradiol on left ventricular function at rest and exercise in postmenopausal women: an echocardiographic assessment. Menopause 1998, 5: 79-85.
36. Pines A, Frenkel Y, Fisman EZ, et al.: The effect of oophorectomy and estrogen replacement therapy on Doppler derived parameters of aortic flow. Maturitas 2000, 37: 125-128.
37. Eckstein N, Pines A, Fisman EZ, et al.: The effect of the hypoestrogenic state, induced by GnRH agonist, on Doppler derived parameters of aortic flow. J Clin Endocrinol Metab 1993, 77: 910-912.
38. Crane MG, Harris JJ: Estrogens and hypertension: effects of discontinuing estrogens on blood pressure, exchangeable sodium, and the rennin-aldosterone system. Am J Med Sci 1978, 276: 33-55.
39. Hatton R, Stimpel M, Chambers TJ: Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 1997, 152: 5-10.
40. Proudler AJ, Ahmed AIH, Crook D, et al.: Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995, 346: 89-90.
41. Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensin-con- verting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342: 145-153.
42. Heart Outcomes Prevention Evaluation (Hope) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000, 355: 253-259.
43. Lee YJ, Chiang YF, Tsai JCR: Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor. Diabetes Care 2000, 23: 427-428.
44. White WB, Koch B, Stimpel M: Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension. Am J Therapeutics 1997, 4: 123-129.
45. Drayer JIM, Stimpel M, Fox A, et al.: The antihypertensive properties of the angiotensin-converting enzyme inhibitor moexipril given alone or in combination with a low dose of a diuretic. Am J Therapeutics 1995, 2: 525-531.
46. Stimpel M, Koch B, Oparil S: Antihypertensive treatment in postmenopausal women: results from a prospective, randomised, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). Cardiology 1998, 89: 271-276.
47. Stimpel M, Koch B, Weber MA: Comparison between moex-ipril and atenolol in obese postmenopausal women with hypertension. Maturitas 1998, 30: 69-77.
48. Agabiti-Rosei E, Ambrosioni E, Pirelli A, et al.: Efficacy and tol-erability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause. Eur J Clin Pharmacol 1999, 55: 185-189.
49. Koch B, Oparil S, Stimpel M: Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women. J Hum Hypertens 1999, 13: 337-342.
50. Cawello W, Boekens H, Waitzinger J, et al.: Moexipril shows a long duration of action related to an extended pharmacoki-netic half-life and prolonged ACE inhibition. Int J Clin Pharmacol Ther 2002, 40: 9-17.
51. Fisman EZ, Tenenbaum A, Motro M: Losartan and diabetic nephropathy: commentaries on the RENAAL study. Cardiovasc Diabetol 2002, 1: 2. Also accessible online at http://www.cardiab.com/content/1/1/2.
52. Fisman EZ, Grossman E, Motro M, et al.: Clinical evidence of dose-dependent interaction between aspirin and angio-tensin-converting enzyme inhibitors. J Hum Hypertens 2002, 16: 379-383.
53. Pines A, Fisman EZ: Hypertension in menopausal women - a special case, for special treatment? Gynecol Endocrinol 2001, 15: 397-405.